ARIKAYCE LIPOSOMAL 590 mg, dispersion for inhalation by nebulizer 28 bottles of 8.43 ml
Active ingredients: Amikacin, Amikacin sulfate
Commercialized according to BDPMDispensing in France: Prescription only
Dispersion for inhalation by nebulizer28 bottles of 8.43 mlinhalée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ARIKAYCE LIPOSOMAL 590 mg, dispersion pour inhalation par nébuliseur
- Pharmaceutical form
- dispersion pour inhalation par nébuliseur
- Route of administration
- inhalée
- Presentation description
- 28 flacons de 8,43 ml avec nébuliseur (LAMIRA) et 4 têtes d'aérosol
- Marketing authorisation holder
- INSMED NETHERLANDS (PAYS-BAS)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 30 Jun 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65156805CIP73021405CIP133400930214053Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SULFATE D'AMIKACINEdispersion | — | SA |
| AMIKACINEdispersion | 590 mg · un flacon | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.